Home > Research > Researchers > Anthony Aggidis
View graph of relations

Anthony Aggidis

Research Associate

Anthony Aggidis

Furness Building

LA1 4YG

Lancaster

Current Research

Professor David Allsop’s research group, following extensive years of research have recently developed a novel retro-inverted peptide-based amyloid beta aggregation inhibitor that may be useful for treatment of Alzheimer’s disease. Tau aggregation inhibitors are a completely new venture for this research group. For my novel PhD research I am pioneering and developing peptide-based tau aggregation inhibitors, testing their interactions with a variety of tau protein aggregation systems and characterising subsequent structures formed from co-incubation. My successful lead tau aggregation inhibitor may be useful as a potential treatment for Alzheimer's disease and perhaps other tauopathies.

View all (4) »